Litigation Details for Rex Medical, L.P. v. Intuitive Surgical, Inc. (D. Del. 2019)
✉ Email this page to a colleague
Rex Medical, L.P. v. Intuitive Surgical, Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-01-02 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | Plaintiff | Referred To | |
Patents | 10,369,135; 10,376,564; 6,297,014; 6,439,572; 7,140,439; 7,309,510; 7,572,779; 7,722,898; 7,906,134; 8,182,831; 8,309,572; 8,415,395; 8,535,779; 8,722,650; 8,906,774; 8,906,885; 8,906,898; 8,980,319; 8,980,885; 9,049,885; 9,439,841; 9,439,886; 9,439,906; 9,517,439; 9,572,779; 9,572,796; 9,650,395; 9,844,510 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Rex Medical, L.P. v. Intuitive Surgical, Inc.
Biologic Drugs cited in Rex Medical, L.P. v. Intuitive Surgical, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Rex Medical, L.P. v. Intuitive Surgical, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-09-20 | 282 | Opinion - Memorandum Opinion | generated by the beam onto the shuttle. (Id. at 295:6-297:14, 350:4-351:7). Defendants contend that Mr. Juergens…Medical’s patents: U.S. Patent No. 9,439,650 (“the ’650 patent”). The invention of the ’650 patent is generally…covers the ’650 patent and ’892 patent along with eight other U.S. patents, seven U.S. patent applications…infringed the ’650 patent as well as U.S. Patent No. 10,136,892 (“the ’892 patent”). (See D.I. 1; see…infringement. 2. Patent Validity An issued patent is presumed valid. See 35 U.S. | External link to document |
2020-05-05 | 76 | Order - -Memorandum and Order | Teva, 135 S. Ct. at 841. Extrinsic evidence “consists of all evidence external to the patent and prosecution…seeking inter partes review of the ’650 Patent.[10] And it does not appear that Plaintiff … uCloudlink Network Tech. Ltd., 376 F. Supp. 3d 369, 381–82 (S.D.N.Y. 2019) (overcoming the SuperGuide…necessary. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 837-38 (2015). “[T]he words of a claim….3d 1370, 1376 (Fed. Cir. 2017); see also Teva, 135 S. Ct. at 842-43. “Any fact critical to a holding | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |